Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Twist Bioscience Sees Q1 Sales $100.000M-$101.000M vs $100.337M Est

Author: Benzinga Newsdesk | November 14, 2025 07:24am
Twist Bioscience (NASDAQ:TWST) sees Q1 sales of $100.000 million-$101.000 million vs $100.337 million analyst estimate.

Posted In: TWST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist